Prime Medicine (PRME) announced the appointment of Svetlana Makhni as Chief Financial Officer, CFO. Ms. Makhni will oversee Prime Medicine’s financial operations and strategy, including investor relations, financial planning and analysis, and corporate development.
Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on PRME:
- Prime Medicine: Prime Editing Platform and PM577 Create Compelling Risk‑Reward in Addressing Unmet Need in Wilson’s Disease
- Oppenheimer bullish on Prime Medicine, initiates with an Outperform
- Prime Medicine initiated with an Outperform at Oppenheimer
- Largest borrow rate increases among liquid names
- Prime Medicine Reports 2025 Results, Advances Gene Editing Pipeline